Drug metabolism, danger signals, and drug-induced hypersensitivity

被引:54
作者
Gruchalla, RS [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Div Allergy & Immunol, Dallas, TX 75390 USA
关键词
adverse drug reactions; allergic drug reactions; drug determinants; drug metabolism; danger hypothesis;
D O I
10.1067/mai.2001.118509
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
One of the most difficult challenges for the practicing allergist/immunologist today is that of evaluating and managing patients who present with histories of drug-induced reactions. Adverse drug reactions are heterogenous, and a single drug can often cause a multitude of reactions. Because the mechanisms responsible for many of these reactions are not known, they can be, and often are, difficult to classify. Moreover, for those that have features consistent with immune-mediated mechanisms, our diagnostic tools remain limited, because little is known about the relevant immunogenic determinants of most drugs. Despite these challenges, management approaches must be devised for patients who present with histories of drug-induced disease. Simply telling such a patient to avoid all drugs that have been associated with previous adverse events leaves both the patient and the referring physician frustrated. The initial part of this review focuses on exciting current research that is furthering our understanding of the mechanisms responsible for drug-induced reactions. Because it will take time to translate this new information into clinical practice, the latter part of the review focuses on ways to evaluate and manage patients who present with drug-induced reactions using the tools and the knowledge that are currently available.
引用
收藏
页码:475 / 488
页数:14
相关论文
共 108 条
[51]  
JANEWAY CA, 1989, COLD SH Q B, V54, P1
[52]   MULTIPLE CYTOCHROME-P450 ISOZYMES IN MURINE SKIN - INDUCTION OF P450 1A, 2B, 2E, AND 3A BY DEXAMETHASONE [J].
JUGERT, FK ;
AGARWAL, R ;
KUHN, A ;
BICKERS, DR ;
MERK, HF ;
MUKHTAR, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (06) :970-975
[53]   SULFONAMIDE-REACTIVE LYMPHOCYTES DETECTED AT VERY-LOW FREQUENCY IN THE PERIPHERAL-BLOOD OF PATIENTS WITH DRUG-INDUCED ERUPTIONS [J].
KALISH, RS ;
LAPORTE, A ;
WOOD, JA ;
JOHNSON, KL .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (03) :465-472
[54]   Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: Implications for allergies, asthma, and autoimmunity [J].
Kalish, RS ;
Askenase, PW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (02) :192-199
[55]  
KALISH RS, 1990, J IMMUNOL, V145, P3706
[56]   PROCESSING OF URUSHIOL (POISON-IVY) HAPTEN BY BOTH ENDOGENOUS AND EXOGENOUS PATHWAYS FOR PRESENTATION TO T-CELLS IN-VITRO [J].
KALISH, RS ;
WOOD, JA ;
LAPORTE, A .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2039-2047
[57]   Cytotoxicity is mandatory for CD8+ T cell-mediated contact hypersensitivity [J].
Kehren, J ;
Desvignes, C ;
Krasteva, M ;
Ducluzeau, MT ;
Assossou, O ;
Horand, F ;
Hahne, M ;
Kägi, D ;
Kaiserlian, D ;
Nicolas, JF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :779-786
[58]   Studies on the sensitization of animals with simple chemical compounds [J].
Landsteiner, K ;
Jacobs, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1935, 61 (05) :643-U8
[60]  
LEVINE BB, 1976, TXB IMMUNOPATHOLOGY, V1, P403